Zhenge Biotech

About:

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

Website: http://www.zgbiotech.com/

Top Investors: Qiming Venture Partners, Novo Holdings, Cowin Capital, Goldman Sachs Asset Management, IDG Capital

Description:

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

Total Funding Amount:

$236M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2017-11-07

Founders:

Jianxin Chen

Number of Employees:

501-1000

Last Funding Date:

2022-08-18

IPO Status:

Private

Industries: